Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response
- PMID: 32335367
- PMCID: PMC7165108
- DOI: 10.1016/j.dsx.2020.04.020
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response
Abstract
Background and aim: As a result of its rapid spread in various countries around the world, on March 11, 2020, WHO issued an announcement of the change in coronavirus disease 2019 status from epidemic to pandemic disease. The virus that causes this disease is indicated originating from animals traded in a live animal market in Wuhan, China. Severe Acute Respiratory Syndrome Coronavirus 2 can attack lung cells because there are many conserved receptor entries, namely Angiotensin Converting Enzyme-2. The presence of this virus in host cells will initiate various protective responses leading to pneumonia and Acute Respiratory Distress Syndrome. This review aimed to provide an overview related to this virus and examine the body's responses and possible therapies.
Method: We searched PubMed databases for Severe Acute Respiratory Syndrome Coronavirus-2, Middle East respiratory syndrome-related coronavirus and Severe Acute Respiratory Syndrome Coronavirus. Full texts were retrieved, analyzed and developed into an easy-to-understand review.
Results: We provide a complete review related to structure, origin, and how the body responds to this virus infection and explain the possibility of an immune system over-reaction or cytokine storm. We also include an explanation of how this virus creates modes of avoidance to evade immune system attacks. We further explain the therapeutic approaches that can be taken in the treatment and prevention of this viral infection.
Conclusion: In summary, based on the structural and immune-evasion system of coronavirus, we suggest several approaches to treat the disease.
Keywords: ACE2; COVID-19; Pandemic; SARS-CoV-2; Wuhan.
Copyright © 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of competing interest None declared.
Figures
Similar articles
-
LY6E impairs coronavirus fusion and confers immune control of viral disease.Nat Microbiol. 2020 Nov;5(11):1330-1339. doi: 10.1038/s41564-020-0769-y. Epub 2020 Jul 23. Nat Microbiol. 2020. PMID: 32704094 Free PMC article.
-
Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection.Front Immunol. 2020 May 12;11:1022. doi: 10.3389/fimmu.2020.01022. eCollection 2020. Front Immunol. 2020. PMID: 32574260 Free PMC article. Review.
-
Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.Infect Dis Poverty. 2020 Jul 20;9(1):99. doi: 10.1186/s40249-020-00691-6. Infect Dis Poverty. 2020. PMID: 32690096 Free PMC article. Review.
-
The Immune Response and Immunopathology of COVID-19.Front Immunol. 2020 Aug 26;11:2037. doi: 10.3389/fimmu.2020.02037. eCollection 2020. Front Immunol. 2020. PMID: 32983152 Free PMC article. Review.
-
Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections.Front Immunol. 2020 Aug 18;11:1979. doi: 10.3389/fimmu.2020.01979. eCollection 2020. Front Immunol. 2020. PMID: 32973803 Free PMC article. Review.
Cited by
-
Interactions of SARS-CoV-2 with the Blood-Brain Barrier.Int J Mol Sci. 2021 Mar 6;22(5):2681. doi: 10.3390/ijms22052681. Int J Mol Sci. 2021. PMID: 33800954 Free PMC article. Review.
-
Flavonoids are promising safe therapy against COVID-19.Phytochem Rev. 2022;21(1):291-312. doi: 10.1007/s11101-021-09759-z. Epub 2021 May 22. Phytochem Rev. 2022. PMID: 34054380 Free PMC article. Review.
-
Differential gene expression analysis of common target genes for the detection of SARS-CoV-2 using real time-PCR.AMB Express. 2022 Sep 2;12(1):112. doi: 10.1186/s13568-022-01454-2. AMB Express. 2022. PMID: 36053466 Free PMC article.
-
Virtual screening by targeting proteolytic sites of furin and TMPRSS2 to propose potential compounds obstructing the entry of SARS-CoV-2 virus into human host cells.J Tradit Complement Med. 2022 Jan;12(1):6-15. doi: 10.1016/j.jtcme.2021.04.001. Epub 2021 Apr 12. J Tradit Complement Med. 2022. PMID: 33868970 Free PMC article.
-
The role of mesenchymal stromal cells in immune modulation of COVID-19: focus on cytokine storm.Stem Cell Res Ther. 2020 Sep 18;11(1):404. doi: 10.1186/s13287-020-01849-7. Stem Cell Res Ther. 2020. PMID: 32948252 Free PMC article. Review.
References
-
- Coronavirus W.H.O. WHO; 2020. COVID-19.https://who.sprinklr.com/
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous